Healthcare
By
Can Novartis’ 19 New Cardiovascular Studies at ESC 2025 Redefine the Future of Heart Disease Treatment?
Key Insights Leqvio: Can Inclisiran’s Expanding Role Become a Game-Changer in Cholesterol Management?Novartis is spotlighting the VICTORION-Difference study,…
Will MEDvidi’s AI Clinician and AI Receptionist Set New Standards in Telehealth?
MEDvidi, a platform for delivering remote, personalized mental health treatment, is launching AI-powered healthcare solutions for telemedicine platforms.…
Can Labcorp’s AI-Powered Test Finder Redefine Diagnostic Efficiency for 750+ Health Systems Nationwide?
Key Highlights Expansion Into Clinical WorkflowsLabcorp (NYSE: LH) announced the integration of its AI-driven Test Finder into Labcorp…
Can Ambience Healthcare’s $243M Series C Push the AI Scribing Market Toward a $5B Future?
Key Highlights Record Funding and Unicorn StatusAmbience Healthcare, founded in 2020 in San Francisco, announced a $243 million…
Is Merck’s £1B Exit Forcing AstraZeneca, Lilly, and Sanofi to Rethink UK’s Life Sciences Future?
Key Insights Merck Triggers Domino Effect with £1B Withdrawal Merck’s decision to abandon its £1-billion London R&D facility…
Will AbbVie’s Rinvoq Patent Deal Lock Out Generics Until 2037—Securing a $31B Immunology Stronghold?
Key Highlights: Patent Shield Extended Through SettlementsAbbVie has successfully resolved litigation with multiple generic challengers—including Sandoz, Aurobindo, Intas,…
